Loading...
•
Dec 31, 2023
Amedisys Q4 2023 Earnings Report
Amedisys's Q4 2023 financial results reflected a slight increase in net service revenue, offset by a decrease in net income due to merger-related expenses.
Key Takeaways
Amedisys reported a slight increase in net service revenue for Q4 2023, but net income was negatively impacted by merger-related costs. The company's adjusted EBITDA also saw a decrease compared to the previous year.
Net service revenue increased to $570.8 million from $562.0 million in Q4 2022.
Net income attributable to Amedisys, Inc. was $19.3 million, compared to $31.7 million in Q4 2022, impacted by $11.5 million in merger transaction costs.
Adjusted EBITDA decreased to $56.7 million from $59.9 million in the prior year.
Adjusted net income attributable to Amedisys, Inc. was $30.8 million, compared to $38.0 million in 2022.
Forward Guidance
Amedisys will not conduct a quarterly earnings call to discuss the fourth quarter and year ended December 31, 2023 results in light of the pending merger of the Company with UnitedHealth Group Incorporated.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...